GAMMA Investing LLC Has $2.29 Million Stock Position in CME Group Inc. $CME

Key Points

• GAMMA Investing LLC increased its stake in CME Group Inc. by 18.4%, now owning 8,297 shares valued at approximately $2.29 million.
• Several hedge funds have made significant investments in CME Group, with GQG Partners LLC raising its stake by an astonishing 7,676.3%.
• CME Group recently declared a quarterly dividend of $1.25 per share, resulting in an annualized yield of 1.9%.

GAMMA Investing LLC lifted its position in CME Group Inc. (NASDAQ:CME - Free Report) by 18.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,297 shares of the financial services provider's stock after buying an additional 1,290 shares during the quarter. GAMMA Investing LLC's holdings in CME Group were worth $2,287,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of CME. U.S. Capital Wealth Advisors LLC boosted its holdings in CME Group by 3.9% in the second quarter. U.S. Capital Wealth Advisors LLC now owns 40,307 shares of the financial services provider's stock valued at $11,109,000 after acquiring an additional 1,500 shares during the last quarter. Park Avenue Securities LLC grew its holdings in CME Group by 62.0% in the 2nd quarter. Park Avenue Securities LLC now owns 21,829 shares of the financial services provider's stock valued at $6,017,000 after buying an additional 8,355 shares in the last quarter. Avanza Fonder AB lifted its position in shares of CME Group by 18.0% during the 2nd quarter. Avanza Fonder AB now owns 26,556 shares of the financial services provider's stock valued at $7,319,000 after acquiring an additional 4,052 shares during the period. Farther Finance Advisors LLC lifted its position in shares of CME Group by 2.2% during the 2nd quarter. Farther Finance Advisors LLC now owns 5,626 shares of the financial services provider's stock worth $1,551,000 after buying an additional 120 shares during the last quarter. Finally, UMB Bank n.a. raised its position in CME Group by 1.5% in the second quarter. UMB Bank n.a. now owns 74,351 shares of the financial services provider's stock valued at $20,493,000 after purchasing an additional 1,068 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In related news, Director William R. Shepard purchased 256 shares of CME Group stock in a transaction that occurred on Wednesday, June 25th. The shares were acquired at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the transaction, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Timothy Francis Mccourt sold 379 shares of the company's stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,043 shares of company stock valued at $3,527,956 over the last three months. 0.30% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts recently issued reports on CME shares. Citigroup lifted their target price on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday, July 3rd. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Piper Sandler upped their price target on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. Barclays set a $298.00 target price on CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Finally, UBS Group cut their price objective on CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research report on Monday, September 8th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $260.60.

CME Group Stock Down 0.2%

CME stock traded down $0.45 during midday trading on Monday, hitting $261.08. The company's stock had a trading volume of 1,143,012 shares, compared to its average volume of 1,903,585. The firm has a 50-day simple moving average of $271.66 and a 200-day simple moving average of $270.86. CME Group Inc. has a 52-week low of $212.60 and a 52-week high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $94.09 billion, a P/E ratio of 25.27, a PEG ratio of 4.73 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the firm earned $2.56 earnings per share. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is currently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.